River Biomedics B.v.

River Biomedics B.v. is an SME in Enschede, Netherlands that has taken part in 2 EU-funded projects since 2022, receiving €2.5M in EU funding and leading 1 as coordinator.

EU funding received€2.5M
EU projects2
As coordinator1
Running now1
First EU project2022
Latest project2023
CountryNetherlands
EU registration (PIC)890086066
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are River Biomedics B.v.'s own share of each project, not the project's full budget.

  • Horizon Europe€2.5M · 2 projects

Projects

2 EU-funded projects, newest first. River Biomedics B.v. led 1 of them as coordinator. Each links to the official record.

  • 3DCardiacHTSCoordinator

    Bringing 3D cardiac tissues to high throughput for drug discovery screens

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €1.5Mtheir share
  • BioRobot-MiniHeartPartner

    Engineering a living human Mini-heart and a swimming Bio-robot

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.0Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biosensing
  • cardiovascular diseases
  • physiology
  • stem cells
  • tissue engineering

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime